This is the authors' abstract. We don't add key points for this paper.
Staphylococcus aureus is one of the most common causes of hospital- and community-acquired infections. Since the recognition of vancomycin-resistant enterococci in 1988, the emergence of vancomycin-resistant S. aureus (VRSA) (minimum inhibitory concentration [MIC] > or = 32 microg/mL) has been anticipated. The transfer of the genetic element containing the vanA vancomycin resistance gene from Enterococcus faecalis to S. aureus was demonstrated in the laboratory in 1992; the first clinical infection with VRSA was reported in July 2002. This report describes the second documented clinical isolate of VRSA from a patient.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
A 2002 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: